Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 613860, 7 pages
http://dx.doi.org/10.1155/2015/613860
Clinical Study

Interaction between the Haptoglobin 2 Phenotype and Diabetes Mellitus on Systolic Pulmonary Arterial Pressure and Nitric Oxide Bioavailability in Hemodialysis Patients

1Diabetic Nephropathy Laboratory, The Baruch Padeh Poriya Medical Center, Faculty of Medicine in the Galilee, 15208 The Lower Galilee, Israel
2Division of Nephrology & Hypertension, The Baruch Padeh Poriya Medical Center, Faculty of Medicine in the Galilee, 15208 The Lower Galilee, Israel
3Division of Vascular Medicine, Holy Family Hospital, 16234 Nazareth, Israel
4Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, 31096 Haifa, Israel
5Department of Physics and Translational Science Center, Wake Forest University, Reynolda Campus, Winston-Salem, NC 27109, USA

Received 19 April 2015; Revised 22 May 2015; Accepted 26 May 2015

Academic Editor: Hiroshi Okamoto

Copyright © 2015 Inbal Dahan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Miller-Lotan, Y. Herskowitz, S. Kalet-Litman et al., “Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus,” Diabetes/Metabolism Research and Reviews, vol. 21, no. 4, pp. 332–337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Yigla, F. Nakhoul, A. Sabag et al., “Pulmonary hypertension in patients with end-stage renal disease,” Chest, vol. 123, no. 5, pp. 1577–1582, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. L. J. Rubin, “Pathology and pathophysiology of primary pulmonary hypertension,” The American Journal of Cardiology, vol. 75, no. 3, pp. 51A–54A, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. M. E. Sise, A. M. Courtwright, and R. N. Channick, “Pulmonary hypertension in patients with chronic and end-stage kidney disease,” Kidney International, vol. 84, no. 4, pp. 682–692, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Archer and S. Rich, “Primary pulmonary hypertension: a vascular biology and translational research ‘work in progress’,” Circulation, vol. 102, no. 22, pp. 2781–2791, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Yigla, S. Dabbah, Z. S. Azzam, A.-H. Rubin, and S. A. Reisner, “Background diseases in 671 patients with moderate to severe pulmonary hypertension,” The Israel Medical Association Journal, vol. 2, no. 9, pp. 684–689, 2000. View at Google Scholar · View at Scopus
  7. M. Yigla, R. Banderski, Z. S. Azzam, S. A. Reisner, and F. Nakhoul, “Arterio-venous access in end-stage renal disease patients and pulmonary hypertension,” Therapeutic Advances in Respiratory Disease, vol. 2, no. 2, pp. 49–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Nakhoul, M. Yigla, R. Gilman, S. A. Reisner, and Z. Abassi, “The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access,” Nephrology Dialysis Transplantation, vol. 20, no. 8, pp. 1686–1692, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Etemadi, H. Zolfaghari, R. Firoozi et al., “Unexplained pulmonary hypertension in peritoneal dialysis and hemodialysis patients,” Revista Portuguesa de Pneumologia, vol. 18, no. 1, pp. 10–14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Yigla, Z. Keidar, I. Safadi, N. Tov, S. A. Reisner, and F. Nakhoul, “Pulmonary calcification in hemodialysis patients: correlation with pulmonary artery pressure values,” Kidney International, vol. 66, no. 2, pp. 806–810, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Barak, F. Nakhoul, and Y. Katz, “Pathophysiology and clinical implications of microbubbles during hemodialysis,” Seminars in Dialysis, vol. 21, no. 3, pp. 232–238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Kawar, T. Ellam, C. Jackson, and D. G. Kiely, “Pulmonary hypertension in renal disease: epidemiology, potential mechanisms and implications,” American Journal of Nephrology, vol. 37, no. 3, pp. 281–290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Yigla, Z. Abassi, S. A. Reisner, and F. Nakhoul, “Pulmonary hypertension in hemodialysis patients: an unrecognized threat,” Seminars in Dialysis, vol. 19, no. 5, pp. 353–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Yigla, O. Fruchter, D. Aharonson et al., “Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients,” Kidney International, vol. 75, no. 9, pp. 969–975, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. T. Gladwin, V. Sachdev, M. L. Jison et al., “Pulmonary hypertension as a risk factor for death in patients with sickle cell disease,” The New England Journal of Medicine, vol. 350, no. 9, pp. 886–895, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. Makuc and D. Petrovič, “A review of oxidative stress related genes and new antioxidant therapy in diabetic nephropathy,” Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 9, no. 4, pp. 253–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Costacou, R. E. Ferrell, and T. J. Orchard, “Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes,” Diabetes, vol. 57, no. 6, pp. 1702–1706, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. P. Levy, K. R. Purushothaman, N. S. Levy et al., “Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability,” Circulation Research, vol. 101, no. 1, pp. 106–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. K. Moestrup and H. J. Moller, “CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response,” Annals of Medicine, vol. 36, no. 5, pp. 347–354, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Timmermann and P. Högger, “Oxidative stress and 8-iso-prostaglandin F2α induce ectodomain shedding of CD163 and release of tumor necrosis factor-α from human monocytes,” Free Radical Biology and Medicine, vol. 39, no. 1, pp. 98–107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Melamed-Frank, O. Lache, B. I. Enav et al., “Structure-function analysis of the antioxidant properties of haptoglobin,” Blood, vol. 98, no. 13, pp. 3693–3698, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Vardi, S. Blum, and A. P. Levy, “Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus—natural history of the disease and the effect of vitamin e treatment. Meta-analysis of the medical literature,” European Journal of Internal Medicine, vol. 23, no. 7, pp. 628–632, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Asleh, J. Guetta, S. Kalet-Litman, R. Miller-Lotan, and A. P. Levy, “Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo,” Circulation Research, vol. 96, no. 4, pp. 435–441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. A. P. Levy, R. Asleh, S. Blum et al., “Haptoglobin: basic and clinical aspects,” Antioxidants & Redox Signaling, vol. 12, no. 2, pp. 293–304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. T. Sertório, R. Lacchini, L. M. Amaral et al., “Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsia,” Journal of Human Hypertension, vol. 27, no. 6, pp. 349–354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. C. D. Reiter, X. D. Wang, J. E. Tanus-Santos et al., “Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease,” Nature Medicine, vol. 8, no. 12, pp. 1383–1389, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. V. C. Sandrim, M. F. Montenegro, A. C. T. Palei et al., “Increased circulating cell-free hemoglobin levels reduce nitric oxide bioavailability in preeclampsia,” Free Radical Biology and Medicine, vol. 49, no. 3, pp. 493–500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Koch, W. Latz, M. Eichinger et al., “Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR,” Clinical Chemistry, vol. 48, no. 9, pp. 1377–1382, 2002. View at Google Scholar · View at Scopus
  29. P. Kleinbongard, A. Dejam, T. Lauer et al., “Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals,” Free Radical Biology and Medicine, vol. 35, no. 7, pp. 790–796, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Lauer, M. Preik, T. Rassaf et al., “Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 22, pp. 12814–12819, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. P. M. Rhodes, A. M. Leone, P. L. Francis, A. D. Struthers, and S. Moncada, “The L-arginine: nitric oxide pathway is the major source of plasma nitrite in fasted humans,” Biochemical and Biophysical Research Communications, vol. 209, no. 2, pp. 590–596, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. D. B. Kim-Shapiro and M. T. Gladwin, “Pitfalls in measuring NO bioavailability using NOx,” Nitric Oxide, vol. 44, pp. 1–2, 2015. View at Publisher · View at Google Scholar
  33. P. Kleinbongard, A. Dejam, T. Lauer et al., “Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans,” Free Radical Biology & Medicine, vol. 40, no. 2, pp. 295–302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Kleinbongard, T. Rassaf, A. Dejam, S. Kerber, and M. Kelm, “Griess method for nitrite measurement of aqueous and protein-containing samples,” Methods in Enzymology, vol. 359, pp. 158–168, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. T. D. Presley, A. R. Morgan, E. Bechtold et al., “Acute effect of a high nitrate diet on brain perfusion in older adults,” Nitric Oxide—Biology and Chemistry, vol. 24, no. 1, pp. 34–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Liu, W. Zhao, G. J. Christ, M. T. Gladwin, and D. B. Kim-Shapiro, “Nitric oxide scavenging by red cell microparticles,” Free Radical Biology and Medicine, vol. 65, pp. 1164–1173, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. A. A. Kenjale, K. L. Ham, T. Stabler et al., “Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease,” Journal of Applied Physiology, vol. 110, no. 6, pp. 1582–1591, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. G. D. Miller, A. P. Marsh, R. W. Dove et al., “Plasma nitrate and nitrite are increased by a high-nitrate supplement but not by high-nitrate foods in older adults,” Nutrition Research, vol. 32, no. 3, pp. 160–168, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Dejam, C. J. Hunter, M. M. Pelletier et al., “Erythrocytes are the major intravascular storage sites of nitrite in human blood,” Blood, vol. 106, no. 2, pp. 734–739, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. D. A. Dobrosielski, T. Presley, A. Perlegas, A. P. Marsh, D. Kim-Shapiro, and W. J. Rejeski, “Plasma nitrite response in older women to a physical function test,” Aging Clinical and Experimental Research, vol. 22, no. 5-6, pp. 383–386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. T. Sertório, E. M. Neto-Neves, C. A. Dias-Junior et al., “Elevated plasma hemoglobin levels increase nitric oxide consumption in experimental and clinical acute pulmonary thromboembolism,” Critical Care Medicine, vol. 41, no. 7, pp. e118–e124, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Asleh, S. Blum, S. Kalet-Litman et al., “Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype,” Diabetes, vol. 57, no. 10, pp. 2794–2800, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. A. I. Alayash, “Oxygen therapeutics: can we tame haemoglobin?” Nature Reviews Drug Discovery, vol. 3, no. 2, pp. 152–159, 2004. View at Google Scholar · View at Scopus
  44. A. I. Alayash, R. P. Patel, and R. E. Cashon, “Redox reactions of hemoglobin and myoglobin: biological and toxicological implications,” Antioxidants and Redox Signaling, vol. 3, no. 2, pp. 313–327, 2001. View at Google Scholar · View at Scopus
  45. J. Watanabe, V. Grijalva, S. Hama et al., “Hemoglobin and its scavenger protein haptoglobin associate with ApoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein,” The Journal of Biological Chemistry, vol. 284, no. 27, pp. 18292–18301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. I. Azarov, X. He, A. Jeffers et al., “Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin,” Nitric Oxide: Biology and Chemistry, vol. 18, no. 4, pp. 296–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Dezfulian, N. J. H. Raat, and M. T. Gladwin, “A pharmacogenomic study of atorvastatin effects on eNOS activity: do ‘statins’ modulate blood nitrite levels and intravascular oxidant stress in susceptible individuals?” Free Radical Biology & Medicine, vol. 41, no. 7, pp. 1041–1043, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Escolar, G. A. Lamas, D. B. Mark et al., “The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT),” Circulation: Cardiovascular Quality and Outcomes, vol. 7, no. 1, pp. 15–24, 2014. View at Publisher · View at Google Scholar · View at Scopus